Respiratory syncytial virus (RSV) is a common and contagious virus that primarily affects the respiratory system, particularly in young children. It can cause symptoms similar to a cold, such as coughing, sneezing, and a runny or stuffy nose. While RSV is usually mild in healthy individuals, it can lead to severe respiratory problems, especially in infants and older adults. RSV is the leading cause of hospitalization in children under the age of one in Canada .
Health Canada has approved a new Pfizer vaccine, Abrysvo, to combat RSV. The vaccine is intended for newborns, from birth to six months of age, who would receive antibodies through maternal immunization, and for people over the age of 60 — both groups who are particularly vulnerable to RSV.
It is important to note that pregnant women are not included in the list of groups who should receive the vaccine .
If you have any concerns about RSV or the vaccine, it is best to contact a qualified medical professional before engaging in any physical activity, or making any changes to your diet, medication or lifestyle .
Comments
Post a Comment